alarin



alarin

A1AA1P2PP2A3AA3H4HH4R5RR5S6SS6S7SS7T8TT8F9FF9P10PP10Q11QQ11R12RR12P13PP13T14TT14R15RR15A16AA16G17GG17R18RR18Q19QQ19T20TT20Q21QQ21L22LL22L23LL23R24RR24S25SS25

SMILES None
InChIKey ZEJHQMBBBMTXNG-JSFGTRHUSA-N
Sequence APAHRSSTFPQRPTRAGRQTQLLRS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


No bioactivity data available.

alarin

A1AA1P2PP2A3AA3H4HH4R5RR5S6SS6S7SS7T8TT8F9FF9P10PP10Q11QQ11R12RR12P13PP13T14TT14R15RR15A16AA16G17GG17R18RR18Q19QQ19T20TT20Q21QQ21L22LL22L23LL23R24RR24S25SS25

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.